{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Bristol-Myers Squibb Company"},"Symbol":{"label":"Symbol","value":"BMY"},"Address":{"label":"Address","value":"430 E. 29TH STREET,14TH FLOOR, NEW YORK, New York, 10016, United States"},"Phone":{"label":"Phone","value":"+1 212 546-4000"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power."},"CompanyUrl":{"label":"Company Url","value":"https://www.bms.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher S. Boerner","title":"Chairman & Chief Executive Officer"},{"name":"Estelle Vester-Blokland","title":"Senior VP-Global Medical Affairs"},{"name":"Greg Meyers","title":"Chief Digital & Technology Officer"},{"name":"Robert M. Plenge","title":"Chief Research Officer, Head-Research & EVP"},{"name":"Samit Hirawat","title":"Chief Medical Officer & EVP-Drug Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}